Compare
DocGo Inc. vs Strata Critical Medical, Inc. vs Verra Mobility Corp vs Gatx Corp
| Latest fiscal year | DocGo Inc. DCGO | Strata Critical Medical, Inc. SRTA | Verra Mobility Corp VRRM | Gatx Corp GATX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $322.20M | $197.14M | $979.08M | $1.74B |
| Revenue growth (YoY) | -47.7% | +34.3% | +11.4% | +9.8% |
| Gross margin | n/a | 20.9% | n/a | n/a |
| Operating margin | -55.3% | -11.3% | 24.4% | n/a |
| Net margin | -56.6% | 21.0% | 14.0% | 19.2% |
| Net income | -$182.40M | $41.35M | $136.63M | $333.30M |
| EPS (Diluted) | -$1.84 | $0.50 | $0.85 | $9.12 |
| Operating cash flow | $34.45M | -$48.91M | $255.80M | $648.10M |
| Free cash flow | $29.91M | -$58.51M | $136.71M | n/a |
| Cash & equivalents | $51.02M | $30.97M | $65.27M | $743.00M |
| Total assets | $217.10M | $325.47M | $1.65B | $18.00B |
| Total liabilities | $91.23M | $46.40M | $1.35B | $14.36B |
| Shareholders' equity | $144.01M | $279.07M | $292.96M | $2.75B |
| Return on year-end equity | -126.7% | 14.8% | 46.6% | 12.1% |
| Shares outstanding | 98.64M | n/a | 153.56M | 35.40M |
Revenue, most recent five fiscal years
| Fiscal year | DocGo Inc. | Strata Critical Medical, Inc. | Verra Mobility Corp | Gatx Corp |
|---|---|---|---|---|
| Latest | $322.20M Ended 2025-12-31 | $197.14M Ended 2025-12-31 | $979.08M Ended 2025-12-31 | $1.74B Ended 2025-12-31 |
| 1 year earlier | $616.56M Ended 2024-12-31 | $146.82M Ended 2024-12-31 | $879.21M Ended 2024-12-31 | $1.59B Ended 2024-12-31 |
| 2 years earlier | $624.29M Ended 2023-12-31 | $225.18M Ended 2023-12-31 | $817.31M Ended 2023-12-31 | $1.41B Ended 2023-12-31 |
| 3 years earlier | $440.52M Ended 2022-12-31 | $146.12M Ended 2022-12-31 | $741.60M Ended 2022-12-31 | $1.27B Ended 2022-12-31 |
| 4 years earlier | $318.72M Ended 2021-12-31 | n/a | $550.59M Ended 2021-12-31 | $1.26B Ended 2021-12-31 |